Study to Determine Effective Dosing of Fondaparinux in Obese Persons
NCT00346879
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Funding withdrawn; study closed due to lack of accrual.
Conditions
Morbid Obesity
Interventions
DRUG:
fondaparinux
Sponsor
Indiana University
Collaborators
[object Object]